Active Ingredient(s): Cefpodoxime
FDA Approved: * August 7, 1992
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vantin Overview

Cefpodoxime is an oral, third-generation cephalosporin antibiotic. It is active against most Gram-positive and Gram-negative organisms. Notable exceptions include Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. Currently, it is only marketed as generic preparations in the US, according to the FDA Orange Book. It is commonly used to treat acute otitis media, pharyngitis, sinusitis, and gonorrhea. It also finds use as oral continuation therapy when intravenous cephalosporins (su...

Read more Vantin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Vantin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • For Suspension: 100mg/5ml, 50mg/5ml
  • Powder for Reconstitution: 100mg/5ml, 50mg/5ml
  • Tablet: 100mg, 200mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vantin: (1 result)

Sorted by National Drug Code
  • 55289-390 Vantin 200 mg Oral Tablet by Pd-rx Pharmaceuticals, Inc.

Other drugs which contain Cefpodoxime or a similar ingredient: (2 results)

Related Vantin Topics: